Tectonic Advisors LLC Abb Vie Inc. Transaction History

Tectonic Advisors LLC

$1.64 Billion
Q3 2025

A detailed history of Tectonic Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tectonic Advisors LLC holds 53,388 shares of ABBV stock, worth $11.6 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

53,388

Previous 50,066 6.64%

Holding current value

$11.6 Million

Previous $9.29 Million 33.01%

% of portfolio

0.75%

Previous 0.55%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	BUY	$184.85 - $231.54 $614,071 - $769,175	3,322 Added 6.64%	53,388 $12.4 Million
Q2 2025 Jul 23, 2025	BUY	$170.16 - $206.27 $963,445 - $1.17 Million	5,662 Added 12.75%	50,066 $9.29 Million
Q1 2025 May 02, 2025	BUY	$169.2 - $216.66 $403,711 - $516,950	2,386 Added 5.68%	44,404 $9.3 Million
Q4 2024 Jan 27, 2025	BUY	$164.99 - $203.87 $939,288 - $1.16 Million	5,693 Added 15.67%	42,018 $7.47 Million
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $646,512 - $786,556	3,946 Added 12.19%	36,325 $7.17 Million
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $380,473 - $444,308	2,458 Added 8.21%	32,379 $5.55 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $160,619 - $183,010	1,005 Added 3.48%	29,921 $5.45 Million
Q4 2023 Jan 17, 2024	BUY	$137.6 - $154.97 $258,963 - $291,653	1,882 Added 6.96%	28,916 $4.48 Million
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $339,585 - $393,120	2,542 Added 10.38%	27,034 $4.03 Million
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $419,924 - $522,568	3,169 Added 14.86%	24,492 $3.3 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $606,928 - $698,968	4,197 Added 24.51%	21,323 $3.4 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $414,100 - $496,614	2,994 Added 21.19%	17,126 $2.77 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $376,727 - $432,081	2,807 Added 24.79%	14,132 $1.9 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $299,873 - $381,237	2,179 Added 23.82%	11,325 $1.73 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $153,228 - $190,113	1,161 Added 14.54%	9,146 $1.48 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $420,373 - $531,894	3,913 Added 96.1%	7,985 $1.08 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $122,572 - $139,138	1,152 Added 39.45%	4,072 $439,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $49,238 - $54,854	468 Added 19.09%	2,920 $329,000
Q1 2021 May 18, 2021	BUY	$102.3 - $112.62 $59,947 - $65,995	586 Added 31.4%	2,452 $266,000
Q4 2020 May 17, 2021	BUY	$80.49 - $108.67 $150,194 - $202,778	1,866 New	1,866 $200,000

Others Institutions Holding ABBV

# of Institutions

4,382

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $386B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tectonic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tectonic Advisors LLC with notifications on news.

Account

Tectonic Advisors LLC Abb Vie Inc. Transaction History